Literature DB >> 17009121

Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis.

Kiyoshi Yamazaki1, Joseph A Murray, Amindra S Arora, Jeffery A Alexander, Thomas C Smyrk, Joseph H Butterfield, Hirohito Kita.   

Abstract

Although the pathogenesis of eosinophilic esophagitis (EE) likely involves hypersensitivity reactions against exogenous allergens, allergen-specific cellular immune responses have not been studied. We investigated allergen-induced cytokine production by peripheral blood mononuclear cells (PBMCs) in adult patients with EE (n=15) and healthy controls (HC; n=9). PBMCs were incubated with nine common food and environmental allergens or a nonspecific mitogen, and the levels of interleukin (IL)-5, IL-10, IL-13, and interferon-gamma in the cell-free supernatants were determined. Spontaneous and mitogen-stimulated cytokine production did not differ between EE and HC. House dust mite, ragweed, Aspergillus, milk, and soy induced significantly higher IL-5 production in EE (P < 0.05). House dust mite also augmented IL-13 production in EE (P < 0.05). Furthermore, PBMCs from three EE patients without allergen-specific IgE vigorously produced IL-5 and IL-13 on allergen stimulation. Thus, immune responses in EE are characterized by enhanced production of Th2-like cytokines against both food and environmental allergens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009121     DOI: 10.1007/s10620-005-9048-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Pathogenesis and clinical features of eosinophilic esophagitis.

Authors:  M E Rothenberg; A Mishra; M H Collins; P E Putnam
Journal:  J Allergy Clin Immunol       Date:  2001-12       Impact factor: 10.793

Review 2.  Eosinophilic esophagitis.

Authors:  Jonathan E Markowitz; Chris A Liacouras
Journal:  Gastroenterol Clin North Am       Date:  2003-09       Impact factor: 3.806

3.  Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts.

Authors:  Victor Turcanu; Soheila J Maleki; Gideon Lack
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

4.  IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy.

Authors:  C Tang; J M Rolland; C Ward; B Quan; E H Walters
Journal:  Eur Respir J       Date:  1997-03       Impact factor: 16.671

5.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Authors:  Anil Mishra; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

6.  Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults.

Authors:  Amindra S Arora; Jean Perrault; Thomas C Smyrk
Journal:  Mayo Clin Proc       Date:  2003-07       Impact factor: 7.616

7.  Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge.

Authors:  S J Till; S R Durham; K Rajakulasingam; M Humbert; D Huston; R Dickason; A B Kay; C J Corrigan
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

Review 8.  Eosinophilic esophagitis: asthma of the esophagus?

Authors:  Amindra S Arora; Kiyoshi Yamazaki
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

9.  Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis.

Authors:  Richard J Noel; Philip E Putnam; Margaret H Collins; Amal H Assa'ad; Jesus R Guajardo; Sean C Jameson; Marc E Rothenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

10.  Allergen-induced cytokine secretion in atopic and non-atopic asthmatic children.

Authors:  Malin F Böttcher; Jenny Bjurström; Xiao-Mei Mai; Lennart Nilsson; Maria C Jenmalm
Journal:  Pediatr Allergy Immunol       Date:  2003-10       Impact factor: 6.377

View more
  25 in total

Review 1.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

Review 2.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

3.  Eosinophilic esophagitis: which role for food and inhalant allergens?

Authors:  Erminia Ridolo; Marcello Montagni; Elisa Olivieri; Anthi Rogkakou; Gian Luigi De' Angelis; Giorgio Walter Canonica
Journal:  Asia Pac Allergy       Date:  2012-10-31

Review 4.  Immunotherapeutic approaches for the treatment of eosinophilic esophagitis.

Authors:  Antonella Cianferoni; Jonathan M Spergel
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

Review 5.  Mechanisms of Disease of Eosinophilic Esophagitis.

Authors:  Benjamin P Davis; Marc E Rothenberg
Journal:  Annu Rev Pathol       Date:  2016-02-24       Impact factor: 23.472

Review 6.  Diagnosis and Management of Eosinophilic Esophagitis.

Authors:  Jeffrey M Wilson; Emily C McGowan
Journal:  Immunol Allergy Clin North Am       Date:  2017-11-06       Impact factor: 3.479

Review 7.  Allergic mechanisms in eosinophilic esophagitis.

Authors:  Joshua B Wechsler; Paul J Bryce
Journal:  Gastroenterol Clin North Am       Date:  2014-03-22       Impact factor: 3.806

8.  Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses.

Authors:  Calman Prussin; Joohee Lee; Barbara Foster
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 9.  Mechanism of eosinophilic esophagitis.

Authors:  Anil Mishra
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

Review 10.  Eosinophilic esophagitis: the newest esophageal inflammatory disease.

Authors:  Dan Atkins; Robert Kramer; Kelley Capocelli; Mark Lovell; Glenn T Furuta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.